Seminars in Hematology
Volume 41, Issue 4 , Pages 303-318 , October 2004

Stem cell clonality and genotoxicity in hematopoietic cells: Gene activation side effects should be avoidable

  • C. von Kalle

      Affiliations

    • Division of Experimental Hematology, Cincinnati Children’s Hospital Research Foundation, Cincinnati, OH
    • Bone Marrow Transplantation, University Hospital Eppendorf, Hamburg, Germany
    • Corresponding Author InformationAddress correspondence to C. von Kalle, MD, Molecular and Gene Therapy Program, Division of Experimental Hematology Cincinnati Children’s Hospital Research Foundation TCHRF R505 ML 7013, 3333 Burnet Ave, Cincinnati, OH 45229
    • ,
  • B. Fehse

      Affiliations

    • Institute for Molecular Medicine and Cell Research and Department of Internal Medicine I, Freiburg University Hospital, Freiburg, Germany
    • ,
  • G. Layh-Schmitt

      Affiliations

    • Division of Experimental Hematology, Cincinnati Children’s Hospital Research Foundation, Cincinnati, OH
    • ,
  • M. Schmidt

      Affiliations

    • Bone Marrow Transplantation, University Hospital Eppendorf, Hamburg, Germany
    • ,
  • P. Kelly

      Affiliations

    • Division of Experimental Hematology, Cincinnati Children’s Hospital Research Foundation, Cincinnati, OH
    • ,
  • C. Baum

      Affiliations

    • Division of Experimental Hematology, Cincinnati Children’s Hospital Research Foundation, Cincinnati, OH
    • Department Hematology and Oncology, Hannover Medical School, Hannover, Germany

References 

  1. Dunbar CE , Young NS . Gene marking and gene therapy directed at primary hematopoietic cells . Curr Opin Hematol . 1996;3:430–437
  2. Hacein-Bey-Abina S , Le Deist F , Carlier F , Bouneaud C , Hue C , De Villartay P , et al.   Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy . N Engl J Med . 2002;18:1185–1193
  3. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, Mortellaro A, et al  Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning . Science . 2002;296:2410–2413
  4. Neff T , Horn PA , Peterson LJ , Thomasson BM , Thompson J , Williams DA , et al.   Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model . J Clin Invest . 2003;112:1581–1588
  5. Kohn DB , Hershfield MS , Carbonaro D , Shigeoka A , Brooks J , Smogorzewska EM , et al.   T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates . Nat Med . 1998;4:775–780
  6. Hacein-Bey-Abina S , von Kalle C , Schmidt M , McCormack MP , Wulffraat N , Leboulch P , et al.   LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 . Science . 2003;302:415–419
  7. Royer-Pokora B , Loos U , Ludwig W-D . TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11) . Oncogene . 1991;6:1887–1893
  8. Wadman IA , Osada H , Grutz GG , Agulnick AD , Westphal H , Forster A , et al.   The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NL1 proteins . EMBO J . 1997;16:3145–3157
  9. Gruetz GG , Bucher K , Lavenir I , Larson T , Larson R , Rabbitts TH . The oncogenic T cell LIM-protein LMO-2 forms part of a DNA-binding complex specifically in immature T cells . EMBO J . 1998;17:4594–4605
  10. Lecuyer E , Herblot S , Saint-Denis M , Martin R , Begley CG , Porcher C , et al.   The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1 . Blood . 2002;100:2430–2440
  11. Xu Z , Huang S , Chang LS , Agulnick AD , Brandt SJ . Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation . Mol Cell Biol . 2003;23:7585–7599
  12. Herblot S , Steff AM , Hugo P , Aplan PD , Hoang T . SCL and LMO1 alter thymocyte differentiation (Inhibition of E2A-HEB function and pre-T alpha chain expression) . Nat Immunol . 2000;1:138–144
  13. McCormack MP , Forster A , Drynan L , Pannell R , Rabbitts TH . The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development . Mol Cell Biol . 2003;23:9003–9013
  14. Crable SC , Anderson KP . A PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene . Blood . 2003;101:4757–4764
  15. McCormack MP , Rabbitts TH . Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency . N Engl J Med . 2004;26:913–922
  16. OMIM, http://www.ncbi.nlm.nih.gov
  17. Baum C , Düllmann J , Li Z , Fehse B , Meyer J , Williams DA , et al.   Side effects of retroviral gene transfer into hematopoietic stem cells . Blood . 2003;101:2099–2114
  18. Pawliuk R , Westerman KA , Fabry ME , Payen E , Tighe R , Bouhassira EE , et al.   Correction of sickle cell disease in transgenic mouse models by gene therapy . Science . 2001;294:2368–2371
  19. Bushman FD . Lateral DNA Transfer (Mechanisms and Consequences) . Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001;
  20. Rynditch AV , Zoubak S , Tsyba L , Tryapitsina-Guley N , Bernardi G . The regional integration of retroviral sequences into the mosaic genomes of mammals . Gene . 1998;22:1–16
  21. Coffin JM , Hughes SH , Varmus HE . Retroviruses . Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1997;
  22. Vjjaya S , Steffan DL , Robinson HL . Acceptor sites for retroviral integrations map near Dnasel-hypersensitive sites in chromatin . J Virol . 1986;60:683–692
  23. Mooslehner K , Karls U , Harbers K . Retroviral integration sites in transgenic Mov mice frequently map in the vicinity of transcribed DNA regions . J Virol . 1990;64:3056–3058
  24. Scherdin U , Rhodes K , Breindl M . Transcriptionally active genome regions are preferred targets for retrovirus integration . J Virol . 1990;64:907–912
  25. Carteau S , Hoffmann C , Bushman FD . Chromosome structure and HIV-1 cDNA integration (Centromeric alphoid repeats are a disfavored target) . J Virol . 1998;72:4005–4014
  26. Leclercq I , Mortreux F , Cavrois M . Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo . J Virol . 2000;74:2305–2312
  27. Weidhaas JB , Angelichio EL , Fenner S . Relationship between retroviral DNA integration and gene expression . J Virol . 2000;74:8382–8389
  28. Pruss D , Bushman FD , Wolffe AP . Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core . Proc Natl Acad Sci USA . 1994;91:5913–5917
  29. Katz RA , DiCandeloro P , Kukolj G . Role of DNA end distortion in catalysis by avian sarcoma virus integrase . J Biol Chem . 2001;276:34213–34220
  30. Scottoline BP , Chow S , Ellison V . Disruption of the terminal base pairs of retroviral DNA during integration . Genes Dev . 1997;11:371–382
  31. Schroder AR , Shinn P , Chen H . HIV-1 integration in the human genome favors active genes and local hotspots . Cell . 2002;110:521–529
  32. Wu X , Li Y , Crise B , Burgess SM . Transcription start regions in the human genome are favored targets for MLV integration . Science . 2003;300:1749–1751
  33. Akagi K , Suzuki T , Stephens RM , Jenkins NA , Copeland NG . RTCGD (Retroviral tagged cancer gene database) . Nucleic Acids Res . 2004;32:D523–D527
  34. Mikkers H , Berns A . Retroviral insertional mutagenesis (Tagging cancer pathways) . Adv Cancer Res . 2003;88:53–99
  35. Donahue RE , Kessler SW , Bodine D , McDonagh K , Dunbar C , Goodman S , et al.   Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer . J Exp Med . 1992;176:1125–1135
  36. Sorensen AB , Duch M , Jorgenses P . Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method . J Virol . 1993;67:7118–7124
  37. Jones DH , Winistorfer SC . Sequence specific generation of a DNA panhandle permits PCR amplification of unknown flanking DNA . Nucl Acids Res . 1992;20:595–600
  38. Silver J , Keerikatte V . Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus . J Virol . 1989;63:1924–1928
  39. Lagerström M , Parik J , Malmgren H . Capture PCR (Efficient amplification of DNA fragments adjacent to a known sequence in human and YAC DNA) . Genome Res . 1991;1:111–119
  40. Valk PJM , Joosten M , Vankan Y . A rapid RT-PCR based method to isolate complementary DNA fragments flanking retrovirus integration sites . Nucleic Acids Res . 1997;25:4419–4421
  41. Hui EK , Wang PC . Strategies for cloning unknown cellular flanking DNA sequences from foreign integrants . Cell Mol Life Sci . 1998;54:1403–1411
  42. Dilloo D , Rill DR , Grossmann ME . Gene marking and gene therapy for transplantation medicine . J Hematol . 1996;5:553–555
  43. Dunbar CE , Young NS . Gene marking and gene therapy directed at primary hematopoietic cells . Curr Opin Hematol . 1996;3:430–437
  44. Dao MA , Nolta JA . Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction . Int J Mol Med . 1998;1:257–264
  45. Nolta JA , Dao MA , Wells S . Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice . Proc Nat Acad Sci USA . 1996;93:2414–2419
  46. Pfeifer GP , Steigerwald SD , Mueller PR . Genomic sequencing and methylation analysis by ligation mediated PCR . Science . 1989;246:810–813
  47. Mueller PR , Wold B . In vivo footprinting of a muscle specific enhancer by ligation mediated PCR . Science . 1989;246:780–786
  48. Izsvak Z , Ivics Z . Two-stage ligation-mediated PCR enhances the detection of integrated transgenic DNA . Biotechniques . 1993;15:814–817
  49. Eggert H , Bergemann K , Saumweber H . Molecular screening for P-element insertions in a large genomic region of Drosophila melanogaster using polymerase chain reaction mediated by the vectorette . Genetics . 1998;149:1427–1434
  50. Prod’hom G , Lagier B , Pelicic V . A reliable amplification technique for the characterization of genomic DNA-sequences flanking insertion sequences . FEMSMicrobiology Letters . 1998;158:75–81
  51. Urata M , Wakiyama M , Iwase M . New sensitive method for the detection of the A3243G mutation of human mitochondrial deoxyribonucleid acid in diabetes mellitus patients by ligation-mediated polymerase chain reaction . Clin Chem . 1998;44:2088–2093
  52. Schupp JM , Price LB , Klevytska A , et al.   Internal and flanking sequence from AFLP fragments using ligation-mediated suppression PCR . Biotechniques . 1999;26:905–912
  53. Schmidt M , Zickler P , Hoffman G , Haas S , Wissler M , Muessig A . Polyclonal long-term repopulating stem cell clones in a primate model . Blood . 2002;8:2737–2743
  54. Li Z , Düllmann J , Schiedlmeier B , Schmidt M , von Kalle C , Meyer J , et al.   Murine leukemia induced by retroviral gene marking . Science . 2002;296:497
  55. Kuramoto K , Follmann DA , Hematti P , Sellers S , Agricola BA , Metzger ME , et al.   The impact of chronic cytokine therapy on clonal dynamics in non-human primates . Blood . 2004;103:4070–4077
  56. Kohn DB , Hershfield MS , Carbonaro D , Shigeoka A , Brooks J , Smogorzewska EM , et al.   T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates . Nat Med . 1998;4:775–780
  57. Schmidt M , Carbonaro DA , Speckmann C , Wissler M , Bohnsack J , Elder M , et al.   Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates . Nat Med . 2003;9:463–468
  58. Laufs S , Gentner B , Nagy KZ , Jauch A , Benner A , Naundorf S , et al.   Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells . Blood . 2003;101:2191–2198
  59. Bartholomew C , Ihle JN . Retroviral insertions 90 kilobases proximal to the Evi-1 myeloid transforming gene activate transcription from the normal promoter . Mol Cell Biol . 1991;11:1820–1828
  60. Carter D , Chakalova L , Osborne CS , Dai YF , Fraser P . Long-range chromatin regulatory interactions in vivo . Nat Genet . 2002;32:623–626
  61. Kiem HP , Sellers S , Thomasson B , Morris JC , Tisdale JF , Horn PA , et al.   Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells (No Progression to Clonal Hematopoiesis or Leukemia) . Mol Ther . 2004;9:389–395
  62. Fehse B , Kustikova OS , Bubenheim M , Baum C . Pois(s)on—It’s a question of dose . Gene Ther . 2004;11:878–881
  63. Kustikova OS , Wahlers A , Kühlcke K , Stähle B , Zander AR , Baum C , et al.   Dose finding with retroviral vectors (Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population) . Blood . 2003;102:3934–3937
  64. Cavazzana-Calvo M , Thrasher A , Mavilio F . The future of gene therapy (Balancing the risks and benefits of clinical trials) . Nature . 2004;427:779–922
  65. Bezzubova O , Silbergleit A , Yamaguchi Iwai Y , Takeda S , Buerstedde JM . Reduced x-ray resistance and homologous recombination frequencies in a RAD54−/− mutant of the chicken DT40 cell line . Cell . 1997;89:185–193
  66. Bushman FD . Targeting survival (integration site selection by retroviruses and LTR-retrotransposons) . Cell . 2003;115:135–138
  67. Rideout WM , Hochedlinger K , Kyba M , Daley GQ , Jaenisch R . Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy . Cell . 2002;109:17–27
  68. Ghosh K , Van Duyne GD . Cre-loxP biochemistry . Methods . 2002;28:374–383
  69. Loonstra A , Vooijs M , Beverloo HB , Allak BA , van Drunen E , Kanaar R , et al.   Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells . Proc Natl Acad Sci USA . 2001;98:9209–9214
  70. Daniel R , Kao G , Taganov K , Greger JG , Favorova O , Merkel G , et al.   Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage process . Proc Natl Acad Sci USA . 2003;100:4778–4783
  71. Li L , Olvera M , Yoder KE , Mitchell RS , Butler SL , Lieber M , et al.   Role of non-homologous DNA end joining pathway in the early steps of retroviral infection . EMBO J . 2001;12:3272–3281
  72. Kim HJ , Tisdale JF , Wu T , Takatoku M , Sellers SE , Zickler P , et al.   Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates . Blood . 2000;96:1–8
  73. Reya T , Morrison SJ , Clarke MF , Weissman IL . Stem cells, cancer, and cancer stem cells . Nature . 2001;414:105–111
  74. Dick JE . Breast cancer stem cells revealed . Proc Natl Acad Sci USA . 2003;100:3547–3549
  75. Dunbar CE , Takatoku M , Donahue RE . The impact of ex vivo cytokine stimulation on engraftment of primitive hematopoietic cells in a non-human primate model . Ann NY Acad Sci . 2001;938:236–244
  76. Takatoku M , Sellers S , Agricola BA , Metzger ME , Kato I , Donahue RE , et al.   Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates . J Clin Invest . 2001;108:447–455
  77. Ayuk FA , Zander AR , Fehse B . T lymphocytes as targets of gene transfer with Moloney type retroviral vectors . Curr Gene Ther . 2001;1:325–337
  78. Berger C , Blau CA , Clackson T , Riddell SR , Heimfeld S . CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy . Blood . 2003;101:476–484
  79. Allsopp RC , Weissman IL . Replicative senescence of hematopoietic stem cells during serial transplantation (Does telomere shortening play a role?) . Oncogene . 2002;21:3270–3273
  80. Thomas CE , Ehrhardt A , Kay MA . Progress and problems with the use of viral vectors for gene therapy . Nat Rev Genet . 2003;4:346–358
  81. Yan XQ , Lacey DL , Saris C , Mu S , Hill D , Hawley RG , et al.   Ectopic overexpression of c-mpl by retroviral-mediated gene transfer suppressed megakaryopoiesis but enhanced erythropoiesis in mice . Exp Hemat . 1999;27:1409–1417
  82. Onishi M , Mui AL , Morikawa Y , Cho L , Kinoshita S , Nolan GP , et al.   Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer . Blood . 1996;88:1399–1406
  83. Neff H . Efficient in vivo selection of hematopoietic stem cells in a large animal model using MGMT and O6BG/temozolomide . Mol Ther . 2003;7:S155; (abstr)
  84. Jin L , Zeng H , Chien S , Otto KG , Richard RE , Emery DW , et al.   In vivo selection using a cell-growth switch . Nat Genet . 2000;26:64–66
  85. Klein C , Nguyen D , Liu CH , Mizoguchi A , Bhan AK , Miki H , et al.   Gene therapy for Wiskott-Aldrich syndrome (Rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice) . Blood . 2003;101:2159–2166
  86. Davé U , Jenkins NA , Copeland NG . Gene therapy insertional mutagenesis insights . Science . 2004;303:333
  87. Hacein-Bey-Abina S , Le Deist F , Carlier F , Bouneaud C , Hue C , De Villartay JP , et al.   Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy . N Engl J Med . 2002;346:1185–1193
  88. Candotti F , Oakes SA , Johnston JA , Giliani S , Schumacher RF , Mella P , et al.   Structural and functional basis for JAK3-deficient severe combined immunodeficiency . Blood . 1997;90:3996–4003
  89. Bunting KD , Sangster MY , Ihle JN , Sorrentino BP . Restoration of lymphocyte function in Janus kinase 3-deficient mice by retroviral-mediated gene transfer . Nat Med . 1998;4:58–64
  90. Migone TS , Lin JX , Cereseto A , Mulloy JC , O’Shea JJ , Franchini G , et al.   Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1 . Science . 1995;269:79–81
  91. Sudbeck EA , Liu XP , Narla RK , Mahajan S , Ghosh S , Mao C , et al.   Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents . Clin Cancer Res . 1999;5:1569–1582
  92. Otsu M , Anderson SM , Bodine DM , Puck JM , O’Shea JJ , Candotti F . Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy . Mol Ther . 2000;1:145–153
  93. Taylor N , Bacon KB , Smith S , Jahn T , Kadlecek TA , Uribe L , et al.   Reconstitution of T cell receptor signaling in ZAP-70-deficient cells by retroviral transduction of the ZAP-70 gene . J Exp Med . 1996;184:2031–2036
  94. Roifman CM , Zhang J , Chitayat D , Sharfe N . A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency . Blood . 2000;96:2803–2807
  95. Antonchuk J , Sauvageau G , Humphries RK . HOXB4-induced expansion of adult hematopoietic stem cells ex vivo . Cell . 2002;109:39–45
  96. Schiedlmeier B , Klump H , Will E , Arman Kalcek G , Li Z , Wang Z , et al.   High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation . Blood. . 2003;101:1759–1768
  97. Buske C , Humphries RK . Homeobox genes in leukemogenesis . Int J Hematol . 2000;71:301–308
  98. Hantzopoulos PA , Suri C , Glass DJ , Goldfarb MP , Yancopoulos GD . The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins . Neuron . 1994;13:187–201
  99. Hamaguchi I , Flygare J , Nishiura H , Brun AC , Ooka A , Kiefer T , et al.   Proliferation deficiency of multipotent hematopoietic progenitors in ribosomal protein S19 (RPS19)-deficient diamond-Blackfan anemia improves following RPS19 gene transfer . Mol Ther . 2003;7:613–622
  100. Fu KL , Foe JR , Joenje H , Rao KW , Liu JM , Walsh CE . Functional correction of Fanconi anemia group A hematopoietic cells by retroviral gene transfer . Blood . 1997;90:3296–3303
  101. Gush KA , Fu KL , Grompe M , Walsh CE . Phenotypic correction of Fanconi anemia group C knockout mice . Blood . 2000;95:700–704
  102. Nakanishi K , Moran A , Hays T , Kuang Y , Fox E , Garneau D , et al.   Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9 . Exp Hematol . 2001;29:842–849
  103. Hanenberg H , Batish SD , Pollok KE , Vieten L , Verlander PC , Leurs C , et al.   Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool . Exp Hematol . 2002;30:410–420
  104. Haneline LS , Li XC , Ciccone SLM , Hong P , Yang Y , et al.   Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc−/− hematopoietic stem cells and decreases the risk of clonal evolution . Blood . 2003;101:1299–1307
  105. Yates F , Malassis-Seris M , Stockholm D , Bouneaud C , Larousserie F , Noguiez-Hellin P , et al.   Gene therapy of RAG-2−/− mice (sustained correction of the immunodeficiency) . Blood . 2002;100:3942–3949
  106. Spanopoulou E , Cortes P , Shih C , Huang CM , Silver DP , Svec P , et al.   Localization, interaction, and RNA binding properties of the V(D)J recombination-activating proteins RAG1 and RAG2 . Immunity . 1995;3:715–726
  107. Moshous D , Callebaut I , de Chasseval R , Corneo B , Cavazzana Calvo M , Le Deist F , et al.   Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency . Cell . 2001;105:177–186
  108. Allay JA , Dumenco LL , Koc ON , Liu L , Gerson SL . Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells . Blood . 1995;85:3342–3351
  109. Bunting KD . ABC transporters as phenotypic markers and functional regulators of stem cells . Stem Cells . 2002;20:11–20
  110. Lorincz MC , Parente MK , Roederer M , Nolan GP , Diwu Z , Martin DI , et al.   Single cell analysis and selection of living retrovirus vector-corrected mucopolysaccharidosis VII cells using a fluorescence-activated cell sorting-based assay for mammalian beta-glucuronidase enzymatic activity . J Biol Chem . 1999;274:657–665
  111. Dunbar CE , Kohn DB , Schiffmann R , Barton NW , Nolta JA , Esplin JA , et al.   Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease (In vivo detection of transduced cells without myeloablation) . Hum Gene Ther . 1998;9:2629–2640
  112. Correll PH , Kew Y , Perry LK , Brady RO , Fink JK , Karlsson S . Expression of human glucocerebrosidase in long-term reconstituted mice following retroviral-mediated gene transfer into hematopoietic stem cells . Hum Gene Ther . 1990;1:277–287
  113. Takenaka T , Murray GJ , Qin G , Quirk JM , Ohshima T , Qasba P , et al.   Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells . Proc Natl Acad Sci USA . 2000;97:7515–7520
  114. Matzner U , Hartmann D , Lullmann Rauch R , Coenen R , Rothert F , Mansson JE , et al.   Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy (Effects on visceral and nervous system disease manifestations) . Gene Ther . 2002;9:53–63
  115. Fillat C , Simonaro CM , Yeyati PL , Abkowitz JL , Haskins ME , Schuchman EH . Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy . J Clin Invest . 1996;98:497–502
  116. Erlich S , Miranda SR , Visser JW , Dagan A , Gatt S , Schuchman EH . Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice (Implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures) . Blood . 1999;93:80–86
  117. Pan D , Aronovich E , McIvor RS , Whitley CB . Retroviral vector design studies toward hematopoietic stem cell gene therapy for mucopolysaccharidosis type I . Gene Ther . 2000;7:1875–1883
  118. Richard E , Mendez M , Mazurier F , Morel C , Costet P , Xia P , et al.   Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection . Mol Ther . 2001;4:331–338
  119. Dinauer MC , Gifford MA , Pech N , Li LL , Emshwiller P . Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease . Blood . 2001;97:3738–3745
  120. Dinauer MC , Li LL , Bjorgvinsdottir H , Ding C , Pech N . Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease . Blood . 1999;94:914–922
  121. Pawliuk R , Westerman KA , Fabry ME , Payen E , Tighe R , Bouhassira EE , et al.   Correction of sickle cell disease in transgenic mouse models by gene therapy . Science . 2001;294:2368–2371
  122. May C , Rivella S , Callegari J , Heller G , Gaensler KM , Luzzatto L , et al.   Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin . Nature . 2000;406:82–86
  123. May C , Rivella S , Chadburn A , Sadelain M . Successful treatment of murine beta- thalassemia intermedia by transfer of the human beta-globin gene . Blood . 2002;99:1902–1908
  124. Aiuti A , Slavin S , Aker M , Ficara F , Deola S , Mortellaro A , et al.   Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning . Science . 2002;296:2410–2413
  125. Schmidt M , Carbonaro DA , Speckmann C , Wissler M , Bohnsack J , Elder M , et al.   Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates . Nat Med . 2003;9:463–468
  126. Nelson DM , Butters KA , Markert ML , Reinsmoen NL , McIvor RS . Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression . J Immunol . 1995;154:3006–3014
  127. Williams DA , Hsieh K , DeSilva A , Mulligan RC . Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate- resistant bone marrow . J Exp Med . 1987;166:210–218
  128. Allay JA , Persons DA , Galipeau J , Riberdy JM , Ashmun RA , Blakley RL , et al.   In vivo selection of retrovirally transduced hematopoietic stem cells . Nat Med . 1998;4:1136–1143
  129. Antonchuk J , Sauvageau G , Humphries RK . HOXB4-induced expansion of adult hematopoietic stem cells ex vivo . Cell . 2002;109:39–45
  130. Hacein Bey Abina S , de Saint Basile G , Cavazzana Calvo M . Gene therapy of X-linked severe combined immunodeficiency . Methods Mol Biol . 2003;215:247–259
  131. Bonini C , Grez M , Traversari C , Ciceri F , Marktel S , Ferrari G , et al.   Safety of retroviral gene marking with a truncated NGF receptor . Nat Med . 2003;9:367–369
  132. Schiedlmeier B , Klump H , Will E , Arman Kalcek G , Li Z , Wang Z , et al.   High-level ectopic HOXB4 expression confers a profound in vivo competitive growth advantage on human cord blood CD34+ cells, but impairs lymphomyeloid differentiation . Blood . 2003;101:1759–1768
  133. Bunting KD . ABC transporters as phenotypic markers and functional regulators of stem cells . Stem Cells . 2002;20:11–20
  134. Leonard WJ . Cytokines and immunodeficiency diseases . Nat Rev Immunol . 2001;1:200–208
  135. Baum C , von Kalle C , Staal FJ , Li Z , Fehse B , Schmidt M , et al.   Chance or necessity? Insertional mutagenesis in gene therapy and its consequences . Mol Ther . 2004;9:5–13
  136. Jin L , Zeng H , Chien S , Otto KG , Richard RE , Emery DW , et al.   In vivo selection using a cell-growth switch . Nat Genet . 2000;26:64–66
  137. Brocard J , Feil R , Chambon P , Metzger D . A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor . Nucleic Acids Res . 1998;26:4086–4090
  138. Brocard J , Feil R , Chambon P , Metzger D . A chimeric Cre recombinase inducible by synthetic, but not by natural ligands of the glucocorticoid receptor . Nucleic Acids Res . 1998;26:4086–4090
  139. Marshall E . Second child in French trial found to have leukemia . Science . 2003;299:320
  140. Alter BP , Young NS . The bone marrow failure syndromes . In:  Nathan DG ,  Oski FA editor. Hematology of Infancy and Childhood . Philadelphia, PA: Saunders; 1997;p. 227–335
  141. Alter BP . Fanconi’s anaemia and its variability . Br J Haematol . 1993;85:9–14
  142. Auerbach AD . Fanconi anemia . Dermatol Clin . 1995;13:41–49
  143. Liu JM , Buchwald M , Walsh CE , Young NS . Fanconi anemia and novel strategies for therapy . Blood . 1994;84:3995–4007
  144. D’Andrea AD , Grompe M . Molecular biology of Fanconi anemia (Implications for diagnosis and therapy) . Blood . 1997;90:1725–1736
  145. Kutler DI , Singh B , Satagopan J , Batish SD , Berwick M , et al.   A 20 year perspective on the International Fanconi Anemia Registry (IFAR) . Blood . 2003;101:1249–1256
  146. Kohli-Kumar M , Morris C , DeLaat C , Sambrano J , Masterson M , et al.   Bone marrow transplantation in Fanconi anemia using matched sibling donors . Blood . 1994;84:2050–2054
  147. Gluckman E , Auerbach AD , Horowitz MM , Sobocinski KA , Ash RC , et al.   Bone marrow transplantation for Fanconi anemia . Blood . 1995;86:2856–2862
  148. MacMillan M , Weisdorf D , DeFor T , Champagne MA , Auerbach AD . Marked reduction in graft failure and regimen related toxicity after unrelated donor hematopoietic cell transplantation in patients with Fanconi anemia (Impact of disease stage and fludarabine) . Blood . 2001;98:670a; (abstr)
  149. Alter BP . Fanconi anemia and malignancies . Am J Hematol . 1996;53:99–110
  150. http://www4.od.nih.gov/oba/rac/minutes/RAC_minutes_12-02.pdf.

PII: S0037-1963(04)00130-1

doi: 10.1053/j.seminhematol.2004.07.007

Seminars in Hematology
Volume 41, Issue 4 , Pages 303-318 , October 2004

Article Tools

* Image Usage & Resolution